Clinical Trial Update: COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at Massachusetts General Hospital is evaluating how coffee and its metabolites affect the gut microbiome in colorectal cancer, and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer, Coffee | Phase 1, Phase 2 | Status: RECRUITING